HIF1A and breast carcinoma: Importantly, the increase of miR-373, HIF1α or TWIST, or the reduction of TXNIP can be used to predict the risk of metastasis in patients with breast cancer, and the highest percentage of lymph node metastases was observed in patients with a combination of the four factors described above (Figure 6F).